More Articles

Access and Evidence

Evolving HTA frameworks to accelerate innovation

Andrew Stone, (Mar 14, 2020)

Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague
Patients and Medical

Advancing through partnerships

Andrew Stone, (Mar 14, 2020)

Collaboration makes sense on many fronts on our journey to sustainably improve the lives of patients, says Merck’s Chris Round
Patients and Medical

Online hospitals – the journey from East to West

Katie Osborne, (Mar 13, 2020)

Artificial intelligence and digital are already transforming medical service delivery in China and it’s heading west rapidly
Patients and Medical

Building an innovation culture

Andrew Stone, (Mar 12, 2020)

Without the right approach to risk and culture, pharma may miss the big opportunities, says Bayer’s Sebastian Guth

Towards the sales force of the near future

Andrew Stone, (Mar 4, 2020)

Blending the digital and the personal can transform engagement, focus sales activity and help meet HCPs’ fast evolving needs if done right

Imagining the ‘Digitome’

Andrew Stone, (Feb 28, 2020)

Dramatic advances in human health beckon if pharma can help build ‘the Digitome’, a vast data commons

The changing nature of pharma sales: A conversation on many levels

Ulrich Neumann, (Feb 20, 2020)

The new approach to sales marries state of the art analytics with a classical approach to engagement

Medical: Pharma’s New North Star

Tom Disley, (Feb 20, 2020)

Already growing in importance, Medical Affairs will become a key differentiator for pharma campanies prepared to adapt and invest in the function

Time to embrace social media

Katie Osborne, (Feb 4, 2020)

Patients are turning to social media as never before and pharma needs to catch up

RWE: A new hope for rare disease

Lucy Fulford, (Jan 30, 2020)

RWE shows great promise in helping accelerate treatments for rare disease